54 related articles for article (PubMed ID: 23464567)
1. Whole-body biodistribution of 3'-deoxy-3'-[(18) f]fluorothymidine ((18) FLT) in healthy adult cats.
Rowe JA; Morandi F; Wall JS; Akula M; Kennel SJ; Osborne D; Martin EB; Galyon GD; Long MJ; Stuckey AC; LeBlanc AK
Vet Radiol Ultrasound; 2013; 54(3):299-306. PubMed ID: 23464567
[TBL] [Abstract][Full Text] [Related]
2. [18F]3'-deoxy-3'-fluorothymidine-PET in NHL patients: whole-body biodistribution and imaging of lymphoma manifestations--a pilot study.
Buchmann I; Neumaier B; Schreckenberger M; Reske S
Cancer Biother Radiopharm; 2004 Aug; 19(4):436-42. PubMed ID: 15453958
[TBL] [Abstract][Full Text] [Related]
3. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.
Zhou M; Wang C; Hu S; Zhang Y; Yao Z; Li J; Guo W; Zhang Y
Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223
[TBL] [Abstract][Full Text] [Related]
4. A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG.
Tian J; Yang X; Yu L; Chen P; Xin J; Ma L; Feng H; Tan Y; Zhao Z; Wu W
J Nucl Med; 2008 Feb; 49(2):186-94. PubMed ID: 18199618
[TBL] [Abstract][Full Text] [Related]
5. Normal thoracic and abdominal distribution of 2-deoxy-2-[18F]fluoro-D-glucose (18FDG) in adult cats.
LeBlanc AK; Wall JS; Morandi F; Kennel SJ; Stuckey A; Jakoby B; Townsend DW; Daniel GB
Vet Radiol Ultrasound; 2009; 50(4):436-41. PubMed ID: 19697611
[TBL] [Abstract][Full Text] [Related]
6. Distribution of 2-deoxy-2-fluoro-d-glucose in the coelom of healthy bald eagles (Haliaeetus leucocephalus).
Jones MP; Morandi F; Wall JS; Long MJ; Stuckey AC; LeBlanc AK
Am J Vet Res; 2013 Mar; 74(3):426-32. PubMed ID: 23438118
[TBL] [Abstract][Full Text] [Related]
7. Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study.
Halpern BS; Dahlbom M; Auerbach MA; Schiepers C; Fueger BJ; Weber WA; Silverman DH; Ratib O; Czernin J
J Nucl Med; 2005 Apr; 46(4):603-7. PubMed ID: 15809482
[TBL] [Abstract][Full Text] [Related]
8. 18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors.
Troost EG; Bussink J; Hoffmann AL; Boerman OC; Oyen WJ; Kaanders JH
J Nucl Med; 2010 Jun; 51(6):866-74. PubMed ID: 20484426
[TBL] [Abstract][Full Text] [Related]
9. Relative skeletal distribution of proliferating marrow in the adult dog determined using 3'-deoxy-3'-[
Rowe JA; Morandi F; Osborne DR; Wall JS; Kennel SJ; Reed RB; LeBlanc AK
Anat Histol Embryol; 2019 Jan; 48(1):46-52. PubMed ID: 30353574
[TBL] [Abstract][Full Text] [Related]
10. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
[TBL] [Abstract][Full Text] [Related]
11. Assessment of blood pool, soft tissue, and skeletal uptake of sodium fluoride F 18 with positron emission tomography-computed tomography in four clinically normal dogs.
Valdés-Martínez A; Kraft SL; Brundage CM; Arceneaux BK; Stewart JA; Gibbons DS
Am J Vet Res; 2012 Oct; 73(10):1589-95. PubMed ID: 23013185
[TBL] [Abstract][Full Text] [Related]
12. Proliferation imaging with ¹⁸F-fluorothymidine PET/computed tomography: physiologic uptake, variants, and pitfalls.
Herrmann K; Buck AK
PET Clin; 2014 Jul; 9(3):331-8. PubMed ID: 25030396
[TBL] [Abstract][Full Text] [Related]
13. Integrated whole-body PET/MR hybrid imaging: clinical experience.
Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
[TBL] [Abstract][Full Text] [Related]
14. Baseline and longitudinal variability of normal tissue uptake values of [
Cysouw MCF; Kramer GM; Frings V; De Langen AJ; Wondergem MJ; Kenny LM; Aboagye EO; Kobe C; Wolf J; Hoekstra OS; Boellaard R
Nucl Med Biol; 2017 Aug; 51():18-24. PubMed ID: 28528264
[TBL] [Abstract][Full Text] [Related]
15. Mapping Radiation Injury and Recovery in Bone Marrow Using 18F-FLT PET/CT and USPIO MRI in a Rat Model.
Rendon DA; Kotedia K; Afshar SF; Punia JN; Sabek OM; Shirkey BA; Zawaski JA; Gaber MW
J Nucl Med; 2016 Feb; 57(2):266-71. PubMed ID: 26315835
[TBL] [Abstract][Full Text] [Related]
16. PET and SPECT imaging in veterinary medicine.
LeBlanc AK; Peremans K
Semin Nucl Med; 2014 Jan; 44(1):47-56. PubMed ID: 24314045
[TBL] [Abstract][Full Text] [Related]
17. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.
Drzezga A; Souvatzoglou M; Eiber M; Beer AJ; Fürst S; Martinez-Möller A; Nekolla SG; Ziegler S; Ganter C; Rummeny EJ; Schwaiger M
J Nucl Med; 2012 Jun; 53(6):845-55. PubMed ID: 22534830
[TBL] [Abstract][Full Text] [Related]
18. First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidine.
Buck AK; Bommer M; Juweid ME; Glatting G; Stilgenbauer S; Mottaghy FM; Schulz M; Kull T; Bunjes D; Möller P; Döhner H; Reske SN
J Nucl Med; 2008 Nov; 49(11):1756-62. PubMed ID: 18927328
[TBL] [Abstract][Full Text] [Related]
19. Automated radiochemical synthesis of pharmaceutical grade [
Mitra A; Chakraborty A; Upadhye T; Tawate M; Lad S; Sahu S; Rajesh C; Bagul S; Pawar Y; Ray MK; Banerjee S
J Labelled Comp Radiopharm; 2022 Jun; 65(8):206-222. PubMed ID: 35466460
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 4'-[methyl-11C]thiothymidine in a rodent tumor and inflammation model.
Toyohara J; Elsinga PH; Ishiwata K; Sijbesma JW; Dierckx RA; van Waarde A
J Nucl Med; 2012 Mar; 53(3):488-94. PubMed ID: 22315439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
